Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus

NCT05188521 is registered in ClinicalTrials.gov with Aaron R. Mangold as lead sponsor.

NCT NCT05188521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05188521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus
Lead sponsor
Aaron R. Mangold
Phase
Phase 2
Overall status
Completed
Start date
January 11, 2022
Completion date
May 17, 2023
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous lichen planus